• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

COPS3 抑制通过调节成骨肉瘤癌细胞中的 PFKFB3 促进细胞增殖阻滞和失巢凋亡。

COPS3 inhibition promotes cell proliferation blockage and anoikis via regulating PFKFB3 in osteosarcoma cancer cells.

机构信息

Department of Bone and Soft Tissue Oncology, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, 450008, China.

Key Laboratory of Precision Oncology in Universities of Shandong, Institute of Precision Medicine, Jining Medical University, Jining, 272067, China.

出版信息

Eur J Pharmacol. 2023 Jul 15;951:175799. doi: 10.1016/j.ejphar.2023.175799. Epub 2023 May 16.

DOI:10.1016/j.ejphar.2023.175799
PMID:37201626
Abstract

As a key component of the COP9 signalosome complex, which participates in a variety of physiological processes, COPS3 is intimately related to multiple cancers. It promotes cell proliferation, progression and metastasis in several cancer cells. However, whether COPS3 participates in regulating anoikis, a specific kind of apoptosis and functions as an essential modulator of cell metastasis, has not yet been studied. Here, we found COPS3 is highly expressed in several cancers especially in osteosarcoma (OS). Overexpression of COPS3 promoted cell proliferation, cell viability and migration/invasion in both control cells and oxaliplatin (Oxa) treated cells. On the contrary, knockdown of COPS3 further enhanced the cytotoxicity of Oxa. Utilizing bioinformatics analysis, we found that COPS3 was higher expressed in the metastatic group, and associated with the extra-cellular matrix (ECM) receptor interaction pathway, which involve in regulating anoikis. In an anoikis model, COPS3 expression varied and genetic modification of COPS3 influenced the cell death enhanced by Oxa. PFKFB3, an essential modulator of glycolysis, was found to interact with COPS3. Inhibition of PFKFB3 promoted apoptosis and anoikis enhanced by Oxa, and COPS3 overexpression failed to rescue this cell death. On the contrary, in the COPS3 knockdown cells, overexpression of PFKFB3 recovered the anoikis resistance, indicating COPS3 function upstream of PFKFB3. In summary, our results elucidated that COPS3 modulated anoikis via affecting PFKFB3 in OS cancer cells.

摘要

作为 COP9 信号体复合物的关键组成部分,参与多种生理过程,COPS3 与多种癌症密切相关。它在几种癌细胞中促进细胞增殖、进展和转移。然而,COPS3 是否参与调节细胞凋亡(一种特殊的细胞程序性死亡形式)以及是否作为细胞转移的重要调节剂尚未得到研究。在这里,我们发现 COPS3 在几种癌症中高度表达,尤其是骨肉瘤(OS)。COPS3 的过表达促进了对照细胞和奥沙利铂(Oxa)处理的细胞中的细胞增殖、细胞活力和迁移/侵袭。相反,COPS3 的敲低进一步增强了 Oxa 的细胞毒性。利用生物信息学分析,我们发现 COPS3 在转移性组中表达更高,并且与细胞外基质(ECM)受体相互作用途径相关,该途径涉及调节细胞凋亡。在细胞凋亡模型中,COPS3 表达发生变化,COPS3 的遗传修饰影响 Oxa 增强的细胞死亡。糖酵解的重要调节剂 PFKFB3 被发现与 COPS3 相互作用。PFKFB3 的抑制促进了由 Oxa 增强的细胞凋亡和细胞凋亡,而过表达的 COPS3 无法挽救这种细胞死亡。相反,在 COPS3 敲低细胞中,过表达 PFKFB3 恢复了对细胞凋亡的抗性,表明 COPS3 功能位于 PFKFB3 上游。总之,我们的结果阐明了 COPS3 通过影响 OS 癌细胞中的 PFKFB3 来调节细胞凋亡。

相似文献

1
COPS3 inhibition promotes cell proliferation blockage and anoikis via regulating PFKFB3 in osteosarcoma cancer cells.COPS3 抑制通过调节成骨肉瘤癌细胞中的 PFKFB3 促进细胞增殖阻滞和失巢凋亡。
Eur J Pharmacol. 2023 Jul 15;951:175799. doi: 10.1016/j.ejphar.2023.175799. Epub 2023 May 16.
2
Novel oncogene COPS3 interacts with Beclin1 and Raf-1 to regulate metastasis of osteosarcoma through autophagy.新型癌基因 COPS3 通过自噬与 Beclin1 和 Raf-1 相互作用调节骨肉瘤的转移。
J Exp Clin Cancer Res. 2018 Jul 3;37(1):135. doi: 10.1186/s13046-018-0791-6.
3
Overexpression of COPS3 promotes clear cell renal cell carcinoma progression via regulation of Phospho-AKT(Thr308), Cyclin D1 and Caspase-3.COPS3 的过表达通过调节磷酸化 AKT(Thr308)、细胞周期蛋白 D1 和半胱氨酸天冬氨酸蛋白酶 3 促进肾透明细胞癌的进展。
Exp Cell Res. 2018 Apr 15;365(2):163-170. doi: 10.1016/j.yexcr.2018.02.025. Epub 2018 Feb 23.
4
PFKFB3 Inhibition Attenuates Oxaliplatin-Induced Autophagy and Enhances Its Cytotoxicity in Colon Cancer Cells.PFKFB3 抑制减轻奥沙利铂诱导的结肠癌细胞自噬并增强其细胞毒性。
Int J Mol Sci. 2019 Oct 30;20(21):5415. doi: 10.3390/ijms20215415.
5
RNAi-mediated COPS3 gene silencing inhibits metastasis of osteogenic sarcoma cells.RNAi 介导的 COPS3 基因沉默抑制成骨肉瘤细胞的转移。
Cancer Gene Ther. 2011 Jun;18(6):450-6. doi: 10.1038/cgt.2011.16. Epub 2011 Mar 25.
6
Knockdown of COPS3 inhibits the progress of prostate cancer through reducing phosphorylated p38 MAPK expression and impairs the epithelial-mesenchymal transition process.敲低 COPS3 通过减少磷酸化 p38MAPK 的表达抑制前列腺癌的进展,并损害上皮-间充质转化过程。
Prostate. 2019 Dec;79(16):1823-1831. doi: 10.1002/pros.23907. Epub 2019 Sep 11.
7
The COPS3-FOXO3 positive feedback loop regulates autophagy to promote cisplatin resistance in osteosarcoma.COPS3-FOXO3 正反馈回路调节自噬以促进骨肉瘤对顺铂的耐药性。
Autophagy. 2023 Jun;19(6):1693-1710. doi: 10.1080/15548627.2022.2150003. Epub 2022 Nov 30.
8
COPS3 Promotes Proliferation, Invasion, and EMT of Colorectal Cancer Cells by MEK/ERK Pathway.COPS3 通过 MEK/ERK 通路促进结直肠癌细胞的增殖、侵袭和 EMT。
Dis Markers. 2022 Jul 19;2022:7594489. doi: 10.1155/2022/7594489. eCollection 2022.
9
ROCK2 promotes osteosarcoma growth and metastasis by modifying PFKFB3 ubiquitination and degradation.ROCK2 通过修饰 PFKFB3 的泛素化和降解促进骨肉瘤的生长和转移。
Exp Cell Res. 2019 Dec 15;385(2):111689. doi: 10.1016/j.yexcr.2019.111689. Epub 2019 Oct 31.
10
Silencing of the COPS3 gene by siRNA reduces proliferation of lung cancer cells most likely via induction of cell cycle arrest and apoptosis.通过小干扰RNA(siRNA)使COPS3基因沉默,最有可能通过诱导细胞周期停滞和凋亡来降低肺癌细胞的增殖。
Asian Pac J Cancer Prev. 2012;13(3):1043-8. doi: 10.7314/apjcp.2012.13.3.1043.

引用本文的文献

1
Proteomic Analysis Highlights the Impact of the Sphingolipid Metabolizing Enzyme β-Galactosylceramidase on Mitochondrial Plasticity in Human Melanoma.蛋白质组学分析强调鞘脂代谢酶β-半乳糖苷酶对人黑色素瘤线粒体可塑性的影响。
Int J Mol Sci. 2024 Mar 6;25(5):3062. doi: 10.3390/ijms25053062.
2
Reprogramming of glucose metabolism: Metabolic alterations in the progression of osteosarcoma.葡萄糖代谢重编程:骨肉瘤进展中的代谢改变。
J Bone Oncol. 2024 Jan 4;44:100521. doi: 10.1016/j.jbo.2024.100521. eCollection 2024 Feb.